Timetable
| 09:00-09:15 | Official opening |
| 09:15-09:40 | Tobias Bald University of Bonn, Germany NK cell plasticity in cancer |
| 09:40-10:05 | Kazuyo Moro RIKEN/Osaka University, Japan The Impact of Appendectomy on Ulcerative Colitis |
| 10:05-10:30 | Jakub Gołąb Medical University of Warsaw, Poland The roles of arginases in mitigation of antitumor immunity |
| 10:30-10:55 | Aurélie Poli Luxembourg Institute of Health, Luxembourg AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection |
| 10:55-11:20 | Alexandros Drainas BioMed X, Germany The quest to eliminate ecDNA in cancer cells |
| 11:20-11:40 | Break |
| 11:40-12:05 | Andrew Shepherd University of Texas MD Anderson Cancer Center, USA Pain neurons control cancer immunosurveillance |
| 12:05-12:30 | Hrvoje Miletic University of Bergen, Norway Cell communication and mitochondria transfer in brain tumors |
| 12:30-12:55 | Anne-Marie Heegaard University of Copenhagen, Denmark Pain in Multiple Myeloma – interaction of the cancer microenvironment with the sensory nervous system |
| 12:55-13:20 | Sébastien Talbot (online) Queen’s University, ON, Canada Peripheral Nerve Injury Induced by Colorectal Cancer: Mechanisms and Implications for Chemotherapy-Induced Peripheral Neuropathy |
| 13:20-14:30 | Break |
| 14:30-14:55 | Claudio Ballabio The Francis Crick Institute, United Kingdom Tumour intrinsic electrical activity drives small-cell lung cancer progression |
| 14:55-15:20 | Yuan Pan (online) University of Texas MD Anderson Cancer Center, USA The Cancer Neuroscience of Neurofibromatosis type 1 (NF1) |
| 15:20-15:45 | Dominika Nowis Medical University of Warsaw, Poland The use of mRNA-based immunotherapies in experimental oncology |
| 15:45-16:10 | Helena Florindo University of Lisbon, Portugal Unveiling Solid Tumor Microenvironment for revolutionary nano-immunotherapies |
| 16:10-17:00 | Break (BPK intro on Matchmaking) |
| 17:00-18:00 | Opening Keynote Melody Swartz University of Chicago, USA The yin and yang of tumor-associated lymphatics in metastasis and anti-tumor immunity |
| 09:00-10:30 | EIT Health Morning Talks Satellite Event |
| 10:30-10:55 | Carlos-Filipe Pereira Lund University, Sweden Empowering Cancer Immunotherapy with Cellular Reprogramming |
| 10:55-11:20 | Rafael Blanco DomĂnguez University of Lisbon, Portugal Delta One T cells in Cancer Immunotherapy |
| 11:20-11:45 | Helen Kakkassery King’s College London, United Kingdom Investigating the immune surveillance mechanisms in atypical responders of stage IV breast cancers following standard of care chemo – and targeted therapies |
| 11:45-12:45 | Conference brunch |
| 12:45-13:10 | Thanussuyah Alaguthurai King’s College London, United Kingdom Translational Research Programme- Facilitating oncology research at Guy’s |
| 13:10-13:35 | Marco Gustav Dresden University of Technology, Germany Deep Learning-based Biomarkers for Precision Oncology |
| 13:35-14:00 | Christoph Klose Charité – Berlin University Medicine, Germany Neuro-immune interactions at barrier surfaces |
| 14:00-14:25 | Varun Venkataramani Heidelberg University, Germany |
| 14:25-15:25 | Company session Molecure, Celon Pharma, Ryvu Therapeutics, International Centre for Cancer Vaccine Science, University of Gdańsk, Ardigen |
| 15:25-15:40 | Official closure |